ESC 365 - When to start and when to stop P2Y12 inhibitors in acute coronary syndromes

ESC Premium Access

When to start and when to stop P2Y12 inhibitors in acute coronary syndromes

Session: Cardiovascular drugs in acute coronary syndromes: when to start and when to stop

Topic: Pharmacology and Pharmacotherapy

Speaker: Professor D. Angiolillo (Jacksonville, US)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Dominick Joseph Angiolillo

University of Florida College of Medicine – Jacksonville, Jacksonville (United States of America)

26 presentations

2 followers

3 more presentations in this session

When to start and when to stop beta-blockers in acute coronary syndromes and (nearly) normal ventricular function

Speaker: Professor E. Puymirat (Paris, FR)

When to start and when to stop ACE-I/ARB in acute coronary syndromes and (nearly) normal ventricular function

Speaker: Doctor B. Gersh (Rochester, US)

Early administration of lipid lowering agents in acute coronary syndromes.

Speaker: Professor C. Cannon (Boston, US)

Access the full session

Cardiovascular drugs in acute coronary syndromes: when to start and when to stop

Speakers: Professor D. Angiolillo, Professor E. Puymirat, Doctor B. Gersh, Professor C. Cannon

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources